首页 › 基金 › Beau Ventures, LLc › CGC
Beau Ventures, LLc 对 CGC 的持仓历史
CANOPY GROWTH CORPORATION · 医疗保健
Beau Ventures, LLc 在 Q3 2026 的 13F 申报中披露持有 CGC(CANOPY GROWTH CORPORATION)90,000 股,市值约 US$81K,约占其申报组合的 0.01%,在其申报持仓中市值排名第 23 位。 Beau Ventures, LLc 最近 4 个申报季度中有 4 个季度披露了 CGC 持仓,最早可追溯至 Q4 2025。
最后更新: 2026-10-24 · 来源: SEC EDGAR Form 13F-HR
Beau Ventures, LLc 对 CGC 的持仓演变
Beau Ventures, LLc 于 Q4 2025 首次披露 CGC 持仓:91,106 股(约 US$104K)。 在 4 次申报中,Beau Ventures, LLc 0 次增持、1 次减持、2 次保持不变。 最近一期申报(Q3 2026)显示持股 90,000 股、市值约 US$81K。
逐季持仓明细
| 季度 | 股数 | 金额 | 变化 |
|---|---|---|---|
| Q4 2025 | 91.11K | $103.86K | 新进 |
| Q1 2026 | 90.00K | $85.43K | 减持 |
| Q2 2026 | 90.00K | $85.50K | 持有 |
| Q3 2026 | 90.00K | $80.66K | 持有 |
折线上的点按变动类型着色;缺失季度表示该季未申报持仓。
关于 CGC 与 13F 数据
CGC(CANOPY GROWTH CORPORATION)属于医疗保健行业。我们追踪的基金中还有 20 只申报持有 CGC,申报仓位最大的包括:GFS Advisors, LLC (US$6.7M)。 根据美国 SEC 规定,管理资产超过 1 亿美元的机构投资者须在每季度结束后 45 天内提交 13F 表,披露其美股多头持仓。该数据不包含空头、大部分期权及海外持仓,因此应将其视为季度快照而非实时仓位。
更多关于 Beau Ventures, LLc
常见问题
How long has Beau Ventures, LLc held CGC?
Beau Ventures, LLc has disclosed CGC holdings in 4 of the last 4 reported quarters, going back to Q4 2025.
What is Beau Ventures, LLc's current position in CGC?
As of Q3 2026, Beau Ventures, LLc holds 90.00K shares of CGC (CANOPY GROWTH CORPORATION), valued at $80.66K, representing 0.01% of its reported portfolio and ranking #23.
Has Beau Ventures, LLc been buying or selling CGC?
In the latest 13F filing (Q3 2026), Beau Ventures, LLc held unchanged its position in CGC.
Which other funds hold CGC?
Other major institutional holders of CGC include GFS Advisors, LLC, among 20 funds with disclosed positions.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.